Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Chronic stress is associated with hormonal changes that are known to affect multiple systems, including the immune and endocrine systems, but the effects of stress on cancer growth and progression are not fully understood. Here, we demonstrate that human ovarian cancer cells exposed to either norepinephrine or epinephrine exhibit lower levels of anoikis, the process by which cells enter apoptosis when separated from ECM and neighboring cells. In an orthotopic mouse model of human ovarian cancer, restraint stress and the associated increases in norepinephrine and epinephrine protected the tumor cells from anoikis and promoted their growth by activating focal adhesion kinase (FAK). These effects involved phosphorylation of FAKY397, which was itself associated with actin-dependent Src interaction with membrane-associated FAK. Importantly, in human ovarian cancer patients, behavioral states related to greater adrenergic activity were associated with higher levels of pFAKY397, which was in turn linked to substantially accelerated mortality. These data suggest that FAK modulation by stress hormones, especially norepinephrine and epinephrine, can contribute to tumor progression in patients with ovarian cancer and may point to potential new therapeutic targets for cancer management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Parallel findings in animal and in vitro models support these data [11, 16–22].”
From Living Well: Protocol for a web-based program to improve quality of life in rural and urban ovarian cancer survivors (2024) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Disruption of epithelial cell-matrix interactions induces apoptosis
Frisch, S., & Francis, H. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.4.619 · Cited by 3,254
Stress-induced immune dysfunction: implications for health
Glaser, R., & Kiecolt-Glaser, J. K. (2005) · Nature Reviews Immunology · doi:10.1038/nri1571 · Cited by 2,190
Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor
Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S., Brissette, W. H., Weringer, E. J., Pollok, B. A., & Connelly, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.695 · Cited by 1,939
Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice
llić, D., Furuta, Y., Kanazawa, S., Takeda, N., Sobue, K., Nakatsuji, N., Nomura, S., Fujimoto, J., Okada, M., Yamamoto, T., et al. (1995) · Nature · doi:10.1038/377539a0 · Cited by 1,830
pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions.
Schaller, M. D., Borgman, C. A., Cobb, B. S., Vines, R. R., Reynolds, A. B., & Parsons, J. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.5192 · Cited by 1,444
Self-citationChronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., Jennings, N. B., Armaiz-Pena, G., Bankson, J. A., Ravoori, M., et al. (2006) · Nature Medicine · doi:10.1038/nm1447 · Cited by 1,320
Self-citationFrisch, S. M., & Screaton, R. A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00251-9 · Cited by 1,249
Signaling through focal adhesion kinase
Schlaepfer, D. D., Hauck, C. R., & Sieg, D. J. (1999) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(98)00052-2 · Cited by 1,175
Control of adhesion-dependent cell survival by focal adhesion kinase.
Frisch, S. M., Vuori, K., Ruoslahti, E., & Chan-Hui, P. Y. (1996) · The Journal of cell biology · doi:10.1083/jcb.134.3.793 · Cited by 1,109
McCarty, K. S., MILLER, L. S., Cox, E. B., Konrath, J. G., & McCarty, K. S. (1985) · PubMed · Cited by 1,027
Research works printed but not linked: 6
- Riley, 1979, Cancer Detect Prev., 2, 235
- Lutgendorf, 2003, Clin Cancer Res., 9, 4514
- Han, 2002, Acta Pharmacol Sin., 23, 490
- 10.1037/0278-6133.4.5.403 · doi:10.1037/0278-6133.4.5.403
- Wu, 1999, Oncol Res., 11, 461
- McCarty, 1985, Arch Pathol Lab Med., 109, 716
Cited by
Items 201–289 of 289
Arese, M., Bussolino, F., Pergolizzi, M., & Bizzozero, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314695 · Cited by 11
Silva, D., Quintas, C., Gonçalves, J., & Fresco, P. (2024) · Cells · doi:10.3390/cells13030262 · Cited by 10
β-Adrenergic Receptors : New Target in Breast Cancer
Wang, T., Li, Y., Lu, H.-L., Meng, Q.-W., Cai, L., & Chen, X.-S. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.18.8031 · Cited by 11
“, 2010) and reduce apoptosis of cancer cells (Sastry et al., 2007; Zhang et al., 2009; Sood et al., 2010; Set al., 2011).”
BackgroundThe complex ecosystem in non small cell lung cancer invasion
Haney, S., Konen, J. M., Marcus, A. I., & Bazhenov, M. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006131 · Cited by 11
“FAK expression is upregulated in 492 ovarian [20] and breast cancer [21] tumors with expression levels correlating with 493 survival [22,23].”
BackgroundChen, L., Qian, J., You, Q., & Ma, J. (2021) · Bioengineered · doi:10.1080/21655979.2021.2000732 · Cited by 9
“In addition, FAK is involved in protecting OC cells from anoikis and apoptosis, which contribute to OC progression in patients [38,39].”
BackgroundLiu, Y., Gu, R., Gao, M., Wei, Y., Shi, Y., Wang, X., Gu, Y.-H., Gu, X., & Zhang, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1126271 · Cited by 9
“Furthermore, the biological properties of malignant tumors, such as cancer cell proliferation, invasion, metastasis, angiogenesis, resistance to apoptos i s , and stromal compartments in the tumor microenvironment, are strongly influenced by epinephrine and norepinephrine (60).”
BackgroundWang, S., Liu, L., Bao, K.-Y., Zhang, Y., Wang, W.-W., Shi, D., Jia, N.-E., Suo, S., Cai, J., Guo, J., et al. (2023) · Current Medical Science · doi:10.1007/s11596-023-2719-4 · Cited by 9
The Nervous System Contributes to the Tumorigenesis and Progression of Human Digestive Tract Cancer
Dai, D., & Liu, H. (2022) · Journal of Immunology Research · doi:10.1155/2022/9595704 · Cited by 10
“Epinephrine and norepinephrine, which are essential components of the fight-or-flight response, are profoundly involved in modulating the microenvironment of tumor tissues by taking part in various biological profiles of tumor cells, such as cell survival, proliferation, antiapoptosis, migration, angiogenesis, and mat…”
BackgroundDong, H., Liao, X., Mai, H., Zhou, N., Wang, D.-Y., Peng, J., & Yang, L. (2017) · PubMed · Cited by 13
Ge, M., Zhang, W., Zhang, W., Zhang, Z., Zeng, X., Deng, L., Wen, M., Lu, X., Shen, X., Li, Z., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.11.001 · Cited by 10
“…metastasis; Proliferation; therapy resistance FAK; b 1/ b 2-AR; GR-SGK1, MKP1, DUSP1 pathway; b 2-AR-MMPs pathway; GR-ROR, YAP/TAZ [36,42,44,190–192] TME: ; T H 1 cell/T H 2 cell-type cytokine ratio; MDSCs; Macrophage recruitment; ; NK cell cytotoxicity b 1/ b 2-AR; ; CXCL4…”
Psychoneuroimmunology and Cancer: Incidence, Progression, and Quality of Life
Fagundes, C. P., Lindgren, M. E., & Kiecolt‐Glaser, J. K. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4866-2_1 · Cited by 12
“Anoikis is inhibited by beta-adrenergic activation of the cell adhesion enzyme, focal adhesion kinase (FAK; pFAKy397) [ 32 ] .”
BackgroundInfluentialEvaluation of Depressive and Anxious Behavior with the Use of Propranolol in Melanoma-Bearing Mice
Berton, J., Ferreira, T. N., Santos, N. P., Ferro, M. M., & Fávero, G. M. (2021) · Brazilian Archives of Biology and Technology · doi:10.1590/1678-4324-2021200428 · Cited by 8
“These same receptors are also involved in the cellular processes of cancer: angiogenesis, metastasis, progression, invasion and apoptosis[14], and are the target receptors for β-blockers, preventing the binding of catecholamines when they are present[15].”
BackgroundI β-bloccanti: nuova prospettiva terapeutica per il melanoma
GIORGI, V. D., Gandini, S., Grazzini, M., Benemei, S., Marchionni, N., & Geppetti, P. (2012) · Recenti Progressi in Medicina · doi:10.1701/1022.11152 · Cited by 8
Beta-arrestins operate an on/off control switch for focal adhesion kinase activity
Alexander, R. A., Lot, I., Saha, K., Abadie, G., Lambert, M., Decosta, E., Kobayashi, H., Beautrait, A., Borrull, A., Asnacios, A., et al. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03471-5 · Cited by 8
Chronic stress in cancer development and progression
Niu, X., Wu, T. H., Zeng, L., Wang, F., Lv, W., Zhang, L., & Zhou, F. (2025) · 中国科学通报:英文版 · doi:10.1016/j.scib.2025.09.034 · Cited by 12
Fallopian tube secreted protein affects ovarian metabolites in high grade serous ovarian cancer
Bergsten, T. M., Levy, S. E., Zink, K. E., Lusk, H. J., Pergande, M. R., Cologna, S. M., Burdette, J. E., & Sanchez, L. M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1042734 · Cited by 7
“The ability of SKOV3 to respond to NE signaling is well-established (Sood et al., 2006; Sood et al., 2010).”
BackgroundDash, S., Yoder, S., Mesa, T., Smith, A., Cen, L., Eschrich, S. A., Armaiz-Peña, G. N., & Monteiro, Á. N. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-93506-z · Cited by 7
Kim, T.-H., Le, M.-T. T., Oh, M., Vazquez-Hidalgo, E., Chavez, B., Lamkin, D. M., Abdou, A., Tan, X. H. M., Christodoulides, A., Farris, C. M., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112676 · Cited by 6
“Indeed, previous studies report that β AR activation impacts focal adhesion kinase (FAK) activity 65 and focal adhesion size, 17 suggesting there may be interplay between β AR signaling and cell-matrix interactions that are mediated through integrins.”
Tiwari, R. K., Rawat, S. G., Rai, S., & Kumar, A. (2025) · Endocrine · doi:10.1007/s12020-025-04161-7 · Cited by 6
Polypharmacology in Old Drug Rediscovery: Drug Repurposing
Wang, Z., & Yang, B. (2022) · Springer eBooks · doi:10.1007/978-3-031-04998-9_13 · Cited by 7
Xu, C., Huo, D., Liu, Y., Zhu, Q., Zhao, J., Liang, J., & Wang, X. (2025) · BMC Cancer · doi:10.1186/s12885-025-14980-6 · Cited by 4
“…renal tubular apoptosis via glucocorticoid receptor-dependent pathways [17], while sympathetic catecholamine surges activate the HIF-2α/VEGF pro-angiogenic pathway in tumor micro-environments through β-adrenergic receptor-dependent mechanisms, synergistically promoting KC pathogenesis [18, 19].”
Chronic stress-related neuroendocrine mediators and ovarian cancer
Du, H., Yu, G., Hu, R., Du, J., & Liu, C. (2025) · Discover Oncology · doi:10.1007/s12672-025-04012-x · Cited by 4
“E and NE protect ovarian cancer cells from anoikis via a focal adhesion kinase (FAK)-mediated signaling pathway initiated by ADRB2 [25].”
Li, L., Zhang, W., Sun, Y., Zhang, W., Lu, M., Wang, J., Jin, Y., & Xi, Q. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28442 · Cited by 4
“It may also be involved in protecting OV cells from nest loss and apoptosis, promoting OV progression [41,42].”
BackgroundAssessment of Resistance to Anoikis in Ovarian Cancer
He, X., CHIEN, J. R., & Shridhar, V. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-547-7_26 · Cited by 4
Shi, Y., Ju, M., Xue, N., Zhang, Y., Liang, L., Sun, X., & Di, X. (2024) · Medicine · doi:10.1097/md.0000000000037362 · Cited by 4
“[7,15] 16–18] The TME consists of various immune cells, mesenchymal-origin cells, and extracellular matrix, [19] which influence tumorigenesis at all stages by directly interacting with tumor cells.”
BackgroundMechanisms of Metastasis of Solid Organ Tumors in the Perioperative Period
Freeman, J. A., Connolly, C. M., & Buggy, D. J. (2016) · International Anesthesiology Clinics · doi:10.1097/aia.0000000000000124 · Cited by 4
“In a number of studies, the activation of tumor cell beta-adrenoceptors promoted the spread of metastases through the increased expression of prometastatic factors and facilitation of angiogenesis.(63,64) Surgery-induced changes also occur in the patient’s cellular and cytokine milieu.”
BackgroundJung, S.-Y., Kho, S., Song, K., Ahn, J., Park, I., Nam, K., Hwang, S., Nam, S.-Y., Cho, S.-J., & Song, J. Y. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4141 · Cited by 4
“In fact, data from the Cancer Genome Atlas database show that the expression of PTK2 mRNA is elevated in approximately 37% of serious ovarian tumors and 26% of invasive breast cancers, and these increased levels are correlated with poor overall survival (7-9).”
Fischer, A., & Ben‐Eliyahu, S. (2018) · Current anesthesiology reports · doi:10.1007/s40140-018-0295-0 · Cited by 4
Pennington, K. P., Schlumbrecht, M., McGregor, B. A., Goodheart, M. J., Heron, L., Zimmerman, B., Telles, R., Zia, S., Penedo, F. J., & Lutgendorf, S. K. (2024) · Contemporary Clinical Trials · doi:10.1016/j.cct.2024.107612 · Cited by 3
Self-citationMa, D., Wang, Y., Sang, L., & Gao, T. (2025) · Oncology and Therapy · doi:10.1007/s40487-025-00410-x · Cited by 3
“[17] and is associated with a more significant negative correlation with overall patient survival [14, 18].”
Chronic stress and cancer progression through neuro‑endocrine‑immune networks (Review)
Zhu, Z., Zhang, X., Yan, J., Wang, M., Lv, Y., Zhang, W., Guo, H., & Zheng, A. (2026) · Oncology Reports · doi:10.3892/or.2026.9128 · Cited by 4
“At the cellular level, β ‑adrenergic inputs engage Src/FAK to confer anoikis resistance and a survival advantage; this mechanism has been validated in human ovarian cancer cells and linked to metastatic spread (54,55).”
Toward an Integrative Analysis of the Tumor Microenvironment in Ovarian Epithelial Carcinoma
Serio, R. N. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0092-5 · Cited by 4
“Phosphorylated FAK may be required to override anoikis in ascitic fluid, and NF-κβ affects transcription of several factors involved in cell growth, endothelial permeabilization and cell migration, such as Snail1, IL-6 and IL-8 [57, 102, 103].”
BackgroundFlorescu, C., Târtea, G. C., Streba, C. T., Pirici, N. D., Puiu, I., Târtea, E. A., Ghiluşi, M. C., Comanescu, M. V., Rogoveanu, I., & Vere, C. C. (2016) · PubMed Central · doi:10.12865/chsj.42.04.01 · Cited by 3
“Thus, beta-adrenergic receptors, whose expression we analyzed in this study, were the subject of many studies in different types of cancer: colorectal [11,12,13,14], ovary [15,16,17,18], breast [19], pancreas [20], prostate [21] and lung [22].”
BackgroundKim, R. T., & Whited, J. L. (2024) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15210 · Cited by 3
“155,156 As such, it is possible that adrenergic signaling may confer systemically activated cells with anoikis resistance by upregulating EMT-TFs.”
stress, A. C. A. U., support, W. A. I. P. S., & [22]., C. D. F. G. P. (2015) · Integrative Cancer Science and Therapeutics · doi:10.15761/icst.1000125 · Cited by 7
Effects of environmental and social stressors on biological rhythms
Sakakibara, H., Yasuda, M. T., & Shimoi, K. (2016) · The Journal of Physical Fitness and Sports Medicine · doi:10.7600/jpfsm.5.143 · Cited by 3
Sarwar, M., Sykes, P. H., Chitcholtan, K., & Evans, J. J. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.04.107 · Cited by 4
Psychoneuroimmunologie und Krebs: Neue Ergebnisse zu psychosozialen Einflüssen auf Tumorerkrankungen
Hefner, J., & Csef, H. (2011) · Der Onkologe · doi:10.1007/s00761-011-2077-x · Cited by 3
Molecular mechanisms and therapeutic targets in lung cancer–nerve crosstalk
Xu, Z., Huang, S., & Chu, Q. (2026) · Chinese Medical Journal - Pulmonary and Critical Care Medicine · doi:10.1016/j.pccm.2026.05.003 · Cited by 2
Focal Adhesion Kinase Related Gynecologic Cancer: a review
Thanapprapasr, D. (2011) · Thai Journal of Obstetrics and Gynaecology · Cited by 2
Aydın, B., Gören, M. Z., Kanlı, Z., & Cabadak, H. (2022) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13627 · Cited by 2
A Network Pharmacology Study to Uncover the Mechanism of FDY003 for Ovarian Cancer Treatment
Lee, H.-S., Lee, I.-H., Kang, K., Park, S., Jung, M., Yang, S. G., Kwon, T.-W., & Lee, D.-Y. (2022) · Natural Product Communications · doi:10.1177/1934578x221075432 · Cited by 2
Repurposing Drugs for Overcoming Therapy Resistance in Colon Cancer – A Review
Darvishi, M., Chekeni, A. M., Fazelhosseini, M., Iqbal, Z., Mirza, M. A., Aslam, M., & Bayrakdar, E. T. A. (2024) · Journal of Angiotherapy · doi:10.25163/angiotherapy.829423 · Cited by 3
Kanczkowski, W., Sue, M., Wlodarczyk, A., & Chrousos, G. P. (2024) · Exploration of Endocrine and Metabolic Diseases · doi:10.37349/eemd.2024.00012 · Cited by 3
Characterization of in vitro metabolism of focal adhesion kinase inhibitors by LC/MS/MS
Chi, Q., Wang, L., Xie, D., & Wang, X. (2019) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2019.02.028 · Cited by 2
Bellastella, A. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734936741.793557350 · Cited by 2
Improving Cancer Survival Through Perioperative Attenuation of Adrenergic-Inflammatory Signaling
Ricon‐Becker, I., Hiller, J. G., & Ben‐Eliyahu, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-69584-8.00009-8 · Cited by 1
Neural remodeling shapes a nerve-dependent metastatic ecosystem in ovarian cancer
Ou, L., Feng, C., Sun, C., Xue, Z., Liu, D., Gong, Q., An, Y., Luo, Y., Sheng, P., Wang, Z., et al. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108463 · Cited by 1
4th international conference on tumor progression and therapeutic resistance: meeting report
Prabhu, V. V., & El‐Deiry, W. S. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1004928 · Cited by 1
“FAK is an important target in ovarian cancer and elevated FAK expression predicts poor survival.(64) Combination of another FAK inhibitor VS-6063 with paclitaxel reduced tumor-initiating capability in ovarian cancer.”
BackgroundPsychoneuroimmunology and Cancer: Biobehavioral Influences on Tumor Progression
Lutgendorf, S. K., Costanzo, E. S., & Sood, A. K. (2012) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780195394399.013.0019 · Cited by 2
Self-citationSocial Genomics and Cancer: Neural Regulation of the Cancer Genome
Knight, J. M., & Cole, S. W. (2022) · Springer eBooks · doi:10.1007/978-3-030-85702-8_21 · Cited by 3
Self-citationHeart failure and cancer: From active exposure to passive adaption
Du, Y., & Wu, T. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.992011 · Cited by 1
“Besides, it confers resistance to apoptosis through various mechanisms, such as inhibition of p53 (87), proapoptotic protein BAD (bcl2 associated death promoter) (88), and anoikis (89).”
BackgroundCaregiver burden and risk of epithelial ovarian cancer in the Nurses’ Health Studies
Barnard, M. E., Poole, E. M., Huang, T., Sood, A. K., Kubzansky, L. D., & Tworoger, S. S. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae185 · Cited by 1
Self-citationSvec, K. V., Kang, M., & Howe, A. K. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.17.508387 · Cited by 1
“There is evidence to support the regulation of FAK downstream of ACs, both promoting FAK activity downstream of increased AC activity [31] or norepinephrine stimulation [54], and decreasing”
BackgroundPlatelets and Anti-Angiogenic Resistance in Ovarian Carcinoma
Bottsford-Miller, J. N. (2012) · Digital Commons-TMC (Texas Medical Center)
Chronic stress promotes tumor growth through increased BDNF production and neo-innervation
Allen, J. K. (2012) · Digital Commons-TMC (Texas Medical Center)
Self-citationKumański, K., & Kamińska, A. (2012)
PTK2 (PTK2 protein tyrosine kinase 2)
Schwock, J., & Dhani, N. C. (2012) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/46033
Perioperative care and cancer recurrence: Is there a connection
Khanna, A. K. (2014) · World Journal of Anesthesiology · doi:10.5313/wja.v3.i1.31 · Cited by 1
Hospitality Houses for Cancer Patients: The Editha House Perspective
Gauwitz, M. L., & Bokhiria, S. D. (2016) · Springer eBooks · doi:10.1007/978-3-319-24814-1_18
A Review of Cancer Immunotherapy and Nutritional Therapies
Westman, J. C. (2017) · Journal of Neoplasm · doi:10.21767/2576-3903.100017
“Many studies have shown that these hormones make breast, ovarian and prostate cancer cells resistant to destruction [24-26].”
BackgroundPsychoneuroimmunologie und Krebs
Hefner, J., & Csef, H. (2017) · Der Onkologe · doi:10.1007/s00761-017-0294-7
“dem Verlust der Zelladhäsion einsetzt [41].”
Case 1—Does the Nearness of Death Diminish the Value of a Life?
Roscoe, L. A., & Schenck, D. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-70920-8_1
An evaluation of perioperative therapies re-purposed for oncoanaesthesia to improve cancer outcomes
Hiller, J. G. (2020) · Figshare · doi:10.26180/12344348
Biochemical Characterization of the Release of FAK Autoinhibition
Hall, J. E. (2017) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.7090
Hassan, S., Pullikuth, A., Nelson, K. C., Flores, A., Karpova, Y., Baiz, D., Zhu, S., Sui, G., Huang, Y., Choi, Y. A., et al. (2023) · doi:10.1158/1541-7786.c.6541105
Ouchérif, S. (2021) · theses.fr (ABES) · doi:10.70675/ac6c6752z608ez4f5bza657z45e51cdf541f · Cited by 1
FATORES DE RISCO COMUNS E TRATAMENTOS EMERGENTES PARA CASOS DE DOENÇAS CARDIOVASCULARES E CÂNCER
Bernardes, A. G. D. C., Wollmann, C. A. R., Horevicht, C. M., Ferreira, I. A. B. D. S., Figueredo, J. C., Ferreira, M. D., Sá, M. C., Senra, P. D. M., & Crepaldi, P. I. S. (2024) · EPITAYA eBooks · doi:10.47879/ed.ep.2024479p521
Mravec, B. (2024) · Springer eBooks · doi:10.1007/978-3-031-68590-3_47
Activating Invasion and Metastasis
Mravec, B. (2024) · Springer eBooks · doi:10.1007/978-3-031-68590-3_17
NeckLymphNet: An Efficient Neck Lymph Node Detection Network for Ultrasound Images
Tan, W., & Zhang, Y. (2025) · International Joint Conference on Neural Networks (IJCNN) · doi:10.1109/ijcnn64981.2025.11227401
Long noncoding RNA BMPR1B-DT promotes anoikis and reduces proliferation in ovarian cancer
Li, Y., Chen, X., Xu, Y., Huang, S., Zhou, C., Tang, Z., Liu, Y., Chen, J., Chen, H., Yang, Y., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-14656-1
“Anoikis resistance is a critical feature of tumour aggressiveness [24–26], chemotherapy resistance [27] and metastasis [18, 21, 28–31].”
Jordan, K. R., Hall, J. K., Schedin, T., Borakove, M., Xian, J. J., Dzieciątkowska, M., Lyons, T. R., Schedin, P. S., Hansen, K. C., & Borges, V. F. (2020) · Figshare · doi:10.6084/m9.figshare.13279121
Jordan, K. R., Hall, J. K., Schedin, T., Borakove, M., Xian, J. J., Dzieciątkowska, M., Lyons, T. R., Schedin, P. S., Hansen, K. C., & Borges, V. F. (2020) · Figshare · doi:10.6084/m9.figshare.13279115
Jordan, K. R., Hall, J. K., Schedin, T., Borakove, M., Xian, J. J., Dzieciątkowska, M., Lyons, T. R., Schedin, P. S., Hansen, K. C., & Borges, V. F. (2020) · Figshare · doi:10.6084/m9.figshare.13279124
Jordan, K. R., Hall, J. K., Schedin, T., Borakove, M., Xian, J. J., Dzieciątkowska, M., Lyons, T. R., Schedin, P. S., Hansen, K. C., & Borges, V. F. (2020) · Figshare · doi:10.6084/m9.figshare.13279118
Risk and resilience in ovarian cancer survivorship
Armer, J. S. (2023) · Iowa Research Online (The University of Iowa) · doi:10.25820/etd.007213
Propranolol dans les hemangiomes infantiles : tolérance et identification des voies thérapeutiques
Prey, S. (2014) · theses.fr (ABES) · doi:10.70675/746aab19z031cz4167zb08ez8c61283e2f23 · Cited by 1
Régulation des tyrosine kinases FAK et Pyk2 par les ß-arrestines
Lot, I. (2021) · theses.fr (ABES) · doi:10.70675/44901d9bz7728z47efz816dze698ae966bbd
Impact des catécholamines sur la progression tumorale des carcinomes hépatocellulaires
Lelou, E. (2022) · theses.fr (ABES) · doi:10.70675/3dc070faz133az4982z9e69z37b1c3d81284
Dehaghani, F. R., Soleimanzadeh, M., Rajabbeigi, E., Shalmani, L. M., Jouni, F. J., & Zafari, J. (2026) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2026.100190
The Energetic Cost of Adrenergic Signaling in Primary Human FibroblastsPreprint
Smith, J. L. M., Sturm, G., & Picard, M. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.09.737569
“We next stimulated fibroblasts with eight doses of norepinephrine up to 10 M, which represents the upper end of estimated NE concentrations at neuroeffector junctions 13 and in the ovarian parenchyma 14 .”
Antitumour Effects of β-Blockers: A Narrative Review of the Literature
Melissaridou, D., Savvidou, O. D., Lianou, I., Kaspiris, A., Korkolopoulou, P. A., Papadimitriou, Ε., & Papagelopoulos, P. J. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48090865
“Recent evidence highlights a central role of β -adrenergic signalling in both tumour and stromal cells in promoting cancer progression through mechanisms such as tumour cell proliferation, angiogenesis, extracellular matrix remodelling, invasion, and immunosuppression [82,83].”
Patrad, E., & Alizadeh, A. M. (2026) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2026.105083
Chen, Y., & Tang, D. (2026) · International Journal of Cancer · doi:10.1002/ijc.70681
Cuello, M. A., Ibáñez, C., Bustos, M., Weiß, C., & Perez‐Cruz, P. E. (2026) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.71460
Metadata
- Authors
- Sood, A. K., Armaiz-Pena, G. N., Halder, J., Nick, A. M., Stone, R. L., Hu, W., Carroll, A. R., Spannuth, W. A., Deavers, M. T., Allen, J. K., Han, L. Y., Kamat, A. A., Shahzad, M. M. K., McIntyre, B. W., Diaz-Montero, C. M., Jennings, N. B., Lin, Y. G., Merritt, W. M., DeGeest, K., Vivas-Mejia, P. E., Lopez-Berestein, G., Schaller, M. D., Cole, S. W., & Lutgendorf, S. K.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Iowa (US)
- West Virginia University (US)
- Corresponding author
- Sood, Anil K.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2010-05-03
- Volume
- 120
- Issue
- 5
- Pages
- 1515-1523
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2860925
- OpenAlex
- W2129041527
- Cited by
- 283
- References
- 58
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 17 · 2023: 14 · 2022: 22 · 2021: 21 · 2020: 19 · 2019: 19 · 2018: 12 · 2017: 13 · 2016: 18 · 2015: 24 · 2014: 18 · 2013: 14 · 2012: 24
- FWCI
- 13.78
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (CA083639, CA101642)
- U.S. Public Health Service (A152737)
- University of Texas MD Anderson Cancer Center (CA101642)
- National Cancer Institute (CA 109298, F31CA126474, R01CA110793, CA 110793, CA 101642, CA-104825, R01CA109298, R01CA104825, R01CA140933, P50CA083639, T32CA101642)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Keywords
- ovarian cancer, anoikis, focal adhesion kinase, adrenergic signaling, norepinephrine, epinephrine, chronic stress, restraint stress, Src kinase, actin, tumor progression, cancer mortality, stress hormones
- MeSH terms
- Actins, Animals, Disease Models, Animal, Epinephrine, Female, Humans, Mice, Nude, Norepinephrine, Ovarian Neoplasms, Phosphorylation, Adrenergic Agents, Anoikis, Cell Line, Tumor, Cell Proliferation, Mice, Focal Adhesion Protein-Tyrosine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.